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Background
The effects of oral and inhaled steroids were investi-
gated in murine models of lung inflammation induced
by 4 or 11 days of exposure to tobacco smoke (TS). The
effects were compared to other anti-inflammatory
compounds.
Methods
Female mice were exposed daily to TS for 4 or 11 days.
Control animals were exposed to air. Mice were killed
24hrs after the last TS-exposure, lungs lavaged and pre-
pared for histological assessment. Steroids were given
orally (dexamethasone (DEX) 300ug/kg; budesonide
(BUD) 10mg/kg, 1hr prior to, and 6hrs after each TS
exposure) or intra-nasally (fluticasone proprionate (FP),
DEX , BUD, beclomethasone, mometasone and cicleso-
nide dosed at 100-500ug/kg 1hr prior to each TS-expo-
sure). Steroid efficacy was also investigated in a mouse
LPS lung inflammation model.
Results
TS-exposure induced a cellular infiltration into the
lungs which was reproducible across more than 50 stu-
dies. The main cell types in the lavage were macro-
phages and neutrophils. Histopathological assessment
showed a progressive increase in pathology from 4 days
of exposure (predominantly vasculitis, alveolar conges-
tion and epithelial hyperplasia) to 11 days of exposure
(bronchiolitis, pneumonitis, bronchiolar degeneration,
bronchial wall remodelling). Steroids dosed via the oral
and intra-nasal routes failed to inhibit this inflammation
in both models (maximal inhibition of TS-induced
inflammation 14%, all p>0.05 compared to controls),
although they caused body weight loss, confirming sys-
temic availability and activity. The doses of steroids
used in the TS studies all showed significant efficacy in
a mouse LPS-model (all >65% inhibition, p<0.05), con-
firming that the TS-exposure model was refractory to
steroids. The TS-induced inflammation was reduced by
PDE4 inhibitors such as Roflumilast when given either
i.n. (total cells 50%, neutrophils 60%, both p<0.05) or
orally (total cells 50%, neutrophils 66%, both p<0.05).
Inhibitors of p38 MAP kinase were effective when given
orally (BIRB796: total cells 42%, neutrophils 55% inhibi-
tion, both p<0.05) or i.n. (PF03715455: total cells 50%,
neutrophils 61% inhibition, both p<0.05). These inhibi-
tory effects were confirmed in multiple studies where
steroids continued to lack efficacy.
Conclusions
TS-exposure for up to 11 days induced lung inflamma-
tion. The inflammatory response was not affected by
doses of steroids which were highly efficacious in a
mouse LPS model. The steroid insensitive effects were
robust and reproducible across multiple studies. The
TS-induced inflammation was inhibited by a clinically
used PDE4 inhibitor (Roflumilast) and p38 inhibitors
such as PF03715455, which is currently in phase I clini-
cal development.
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